The president of the Biden Cancer Initiative shared lessons learned from the White House Cancer Moonshot.
At MM&M's annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation
Experts on using technology to change patient behavior and other topics.
First preventative migraine treatment approved; NIH investigates funding for alcohol study; Trump to block federal funding for abortion clinics.
Biden Cancer Initiative chief gets Transforming Healthcare conference started; Former Novartis CEO on Cohen payments; J&J's Gorsky has advice for Trump on drug pricing plan.
A divisive figure, Sorrell's rise to the top of the ad industry was never dull. Here, we outline the key moments.
Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.
For one of President Trump's proposals for lowering the cost of drugs, the path to implementation could be long.
Read the May 2018 issue in its entirety.
As WPP faces break-up calls in the wake of Sir Martin Sorrell's exit, the agency holding company model is under greater scrutiny than at any time since the 1980s.
Novartis' top lawyer exits after Cohen payments; More states file suit against Purdue Pharma; J&J to relaunch baby line.
Whether jurors will award a pharma Grand Prix, and whether US pharma will show up, are two open questions in the run-up to Lions Health.
Shields will serve as president of the Think Patients subsidiary firm.